ATE520711T1 - Knochenmorphogenetisches protein 4 und osteogene vorrichtungen und pharmazeutische produkte, die dieses enthalten - Google Patents

Knochenmorphogenetisches protein 4 und osteogene vorrichtungen und pharmazeutische produkte, die dieses enthalten

Info

Publication number
ATE520711T1
ATE520711T1 AT06743555T AT06743555T ATE520711T1 AT E520711 T1 ATE520711 T1 AT E520711T1 AT 06743555 T AT06743555 T AT 06743555T AT 06743555 T AT06743555 T AT 06743555T AT E520711 T1 ATE520711 T1 AT E520711T1
Authority
AT
Austria
Prior art keywords
morphogenetic protein
bone morphogenetic
same
products containing
pharmaceutical products
Prior art date
Application number
AT06743555T
Other languages
English (en)
Inventor
Elli Birr
Mari Ulmanen
Oili Hietala
Marja Juustila
Heli Korkala
Pekka Jalovaara
Original Assignee
Bbs Bioactive Bone Substitutes Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FI20055257A external-priority patent/FI121070B/fi
Priority claimed from FI20055258A external-priority patent/FI119373B/fi
Application filed by Bbs Bioactive Bone Substitutes Oy filed Critical Bbs Bioactive Bone Substitutes Oy
Application granted granted Critical
Publication of ATE520711T1 publication Critical patent/ATE520711T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT06743555T 2005-05-27 2006-05-26 Knochenmorphogenetisches protein 4 und osteogene vorrichtungen und pharmazeutische produkte, die dieses enthalten ATE520711T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI20055257A FI121070B (fi) 2005-05-27 2005-05-27 Luun morfogeneettinen proteiini 6, sitä koodaava DNA, nukleotidivektori, rekombinantti isäntäsolu, farmaseuttinen koostumus ja osteogeeninen väline
FI20055258A FI119373B (fi) 2005-05-27 2005-05-27 Luun proteiineja
PCT/FI2006/050213 WO2006125867A1 (en) 2005-05-27 2006-05-26 Bone morphogenetic protein 4 and osteogenic devices and pharmaceutical products containing thereof

Publications (1)

Publication Number Publication Date
ATE520711T1 true ATE520711T1 (de) 2011-09-15

Family

ID=37451666

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06743555T ATE520711T1 (de) 2005-05-27 2006-05-26 Knochenmorphogenetisches protein 4 und osteogene vorrichtungen und pharmazeutische produkte, die dieses enthalten

Country Status (4)

Country Link
US (1) US7807627B2 (de)
EP (1) EP1885750B1 (de)
AT (1) ATE520711T1 (de)
WO (1) WO2006125867A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003066000A2 (en) * 2002-02-08 2003-08-14 Wyeth Formulation comprising bioactive agents and method of using same
WO2011119829A1 (en) * 2010-03-24 2011-09-29 Lifenet Health Bmp-4 peptides & methods of use
US11078248B2 (en) 2010-03-19 2021-08-03 Lifenet Health BMP peptides and methods of use
KR101348284B1 (ko) * 2010-09-09 2014-01-03 주식회사 나이벡 인간 유래 세포 투과성 펩타이드와 생리활성 펩타이드 결합체 및 그 용도

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6150328A (en) * 1986-07-01 2000-11-21 Genetics Institute, Inc. BMP products
US5266683A (en) * 1988-04-08 1993-11-30 Stryker Corporation Osteogenic proteins
US5399677A (en) 1993-12-07 1995-03-21 Genetics Institute, Inc. Mutants of bone morphogenetic proteins
US6083690A (en) * 1995-06-02 2000-07-04 Osteoscreen, Inc. Methods and compositions for identifying osteogenic agents
US20030032586A1 (en) 1997-05-15 2003-02-13 David C. Rueger Compositions for morphogen-induced osteogenesis
US6677432B1 (en) * 1998-10-07 2004-01-13 Stryker Corporation Mutations of the C-terminal portion of TGF-β superfamily proteins
WO2000029012A2 (en) 1998-11-13 2000-05-25 Curis, Inc. Methods of alleviating cancer symptoms

Also Published As

Publication number Publication date
EP1885750A1 (de) 2008-02-13
EP1885750B1 (de) 2011-08-17
WO2006125867A1 (en) 2006-11-30
EP1885750A4 (de) 2009-04-01
US20090214653A1 (en) 2009-08-27
US7807627B2 (en) 2010-10-05

Similar Documents

Publication Publication Date Title
ATE382053T1 (de) System zur antikörperexpression und- synthese
RS51631B (en) 2-AMINO-QUINAZOLINE DERIVATIVES USEFUL AS β-SECRETASE INHIBITORS (BACE)
DE602004014117D1 (de) Thiazole zur verwendung als inhibitoren von protein-kinasen
AU2002305450A1 (en) Proteomimetic compounds and methods
JO2534B1 (en) Pyrimidines carrying alternatives of sulfoximine as CDK and / or VEGF inhibitors and their production and use as pharmaceutical agents
AU2003263552A1 (en) Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules
ATE446313T1 (de) Muteine von tränen-lipocalin
DE60028970D1 (de) An her2 bindende peptidverbindungen
RS51630B (en) 2-AMINO-QUINAZOLINE DERIVATIVES USEFUL AS β-SECRETASE INHIBITORS (BACE)
BR0107613A (pt) Bloqueio do crescimento de axÈnios mediado por receptor nogo
WO2005038012A3 (en) Cartilage and bone repair and regeneration using postpartum-derived cells
EP2213684A3 (de) Nogo-A-Antikörper für die Behandlung von Alzheimer-Krankheit
DE602004024374D1 (de) Zusammensetzungen zur verwendung als protein-kinase-inhibitoren
MA27880A1 (fr) Derives de tetrahydrocarbazole et leur utilisation pharmaceutique
ATE256740T1 (de) Menschliches sdf-5 protein und diesbezügliche zusammensetzungen
EP1978994A4 (de) Bmp-7-varianten-zusammensetzungen, verfahren und verwendungen
DE60313004D1 (de) Alpha-7-nikotinsäure-rezeptoragonisten und statine in kombination
ATE417605T1 (de) Proteine die cross-beta-struktur enthaltendes amyloid binden, sowie verfahren zur modulation der cross-beta-struktur, ihrer bildung und der damit zusammenhängenden toxizität
WO2008100618A3 (en) Carbon-linked tetrahydro-pyrazolo-pyridine modulators of cathepsin s
ATE520711T1 (de) Knochenmorphogenetisches protein 4 und osteogene vorrichtungen und pharmazeutische produkte, die dieses enthalten
ATE533781T1 (de) Heparin-bindungsstelle enthaltendes knochenmorphogenetisches protein 6 und osteogene vorrichtungen und pharmazeutische produkte, die diese enthalten
TW200724679A (en) Treatment of disease using an improved regulated expression system
DK1051491T3 (da) Equin Fc Epsilon receptor-alfa-kæde-nukleinsyremolekyler, korresponderende proteiner og anvendelse heraf
ATE340257T1 (de) Histonedeacetylase 9
WO2008100622A3 (en) Biaryl-substituted tetrahydro-pyrazolo-pyridine modulators of cathepsin s

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties